XGen Venture SGR
XGEN Venture SGR is a Milan-based early-stage venture capital manager investing in European life sciences, backing biotechnology, medtech and diagnostics companies. Founded in 2021 by the former Genextra team, it invests through the EUR 180 million XGEN Venture Life Sciences Fund, which reached its final close in December 2024 with InvestEU support.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
1 fund tracked, 10 portfolio companies (10 active · 0 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
10 companiesFunds & portfolio
Every fund XGen Venture SGR has raised, with its portfolio companies. Hand-checked from public filings.
XGEN Venture Life Sciences FundLife Sciences VC2022 · 4yr€180M10 active
Unrealized
10 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech |  Italy | 2025 | |
| Biotech |  UK | 2025 | |
| Biotech | Italy | 2024 | |
| Biotech |  Sweden | 2025 | |
| Biotech |  Switzerland | 2024 | |
| Biotech | Italy | 2025 | |
| Biotech | Switzerland | 2023 | |
| Biotech | Switzerland | 2024 | |
| MedTech |  Germany | 2024 | |
| Biotech | Italy | 2024 |
Italy· Entry 2025UK· Entry 2025Italy· Entry 2024Sweden· Entry 2025Switzerland· Entry 2024Italy· Entry 2025Switzerland· Entry 2023Switzerland· Entry 2024Germany· Entry 2024Italy· Entry 2024Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Get the full picture on XGen Venture SGR.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in